Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Sienna Diagnostics Inks New Distribution Deal for Bladder Cancer Test

Sienna Diagnostics Inks New Distribution Deal for Bladder Cancer Test

Jan 22, 2019
|
staff reporter

NEW YORK (360Dx) — Sienna Cancer Diagnostics said today that it has signed a South Korean distribution agreement for its bladder cancer diagnostic with Mirax.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Cancer

  1. European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer

    Premium

  2. FDA Accepts Invitae Premarket Approval Submission for Stratafide Companion Diagnostic

  3. Abviris Developing Blood-Based Serology Test For HPV-Related Cancers

    Premium

  4. Tempus Gets CE Mark for xT Tumor Sequencing Assay

  5. Three Investment Banks Initiate Coverage of Biodesix

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.